Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1

Standard

Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. / Lai, Yu-Chiang; Kondapalli, Chandana; Lehneck, Ronny; Procter, James B; Dill, Brian D; Woodroof, Helen I; Gourlay, Robert; Peggie, Mark; Macartney, Thomas J; Corti, Olga; Corvol, Jean-Christophe; Campbell, David G; Itzen, Aymelt; Trost, Matthias; Muqit, Miratul Mk.

In: EMBO J, Vol. 34, No. 22, 12.11.2015, p. 2840-61.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Lai, Y-C, Kondapalli, C, Lehneck, R, Procter, JB, Dill, BD, Woodroof, HI, Gourlay, R, Peggie, M, Macartney, TJ, Corti, O, Corvol, J-C, Campbell, DG, Itzen, A, Trost, M & Muqit, MM 2015, 'Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1', EMBO J, vol. 34, no. 22, pp. 2840-61. https://doi.org/10.15252/embj.201591593

APA

Lai, Y-C., Kondapalli, C., Lehneck, R., Procter, J. B., Dill, B. D., Woodroof, H. I., Gourlay, R., Peggie, M., Macartney, T. J., Corti, O., Corvol, J-C., Campbell, D. G., Itzen, A., Trost, M., & Muqit, M. M. (2015). Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J, 34(22), 2840-61. https://doi.org/10.15252/embj.201591593

Vancouver

Lai Y-C, Kondapalli C, Lehneck R, Procter JB, Dill BD, Woodroof HI et al. Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61. https://doi.org/10.15252/embj.201591593

Bibtex

@article{293e0cff39aa4712ac5881024707d271,
title = "Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1",
abstract = "Mutations in the PTEN-induced kinase 1 (PINK1) are causative of autosomal recessive Parkinson's disease (PD). We have previously reported that PINK1 is activated by mitochondrial depolarisation and phosphorylates serine 65 (Ser(65)) of the ubiquitin ligase Parkin and ubiquitin to stimulate Parkin E3 ligase activity. Here, we have employed quantitative phosphoproteomics to search for novel PINK1-dependent phosphorylation targets in HEK (human embryonic kidney) 293 cells stimulated by mitochondrial depolarisation. This led to the identification of 14,213 phosphosites from 4,499 gene products. Whilst most phosphosites were unaffected, we strikingly observed three members of a sub-family of Rab GTPases namely Rab8A, 8B and 13 that are all phosphorylated at the highly conserved residue of serine 111 (Ser(111)) in response to PINK1 activation. Using phospho-specific antibodies raised against Ser(111) of each of the Rabs, we demonstrate that Rab Ser(111) phosphorylation occurs specifically in response to PINK1 activation and is abolished in HeLa PINK1 knockout cells and mutant PINK1 PD patient-derived fibroblasts stimulated by mitochondrial depolarisation. We provide evidence that Rab8A GTPase Ser(111) phosphorylation is not directly regulated by PINK1 in vitro and demonstrate in cells the time course of Ser(111) phosphorylation of Rab8A, 8B and 13 is markedly delayed compared to phosphorylation of Parkin at Ser(65). We further show mechanistically that phosphorylation at Ser(111) significantly impairs Rab8A activation by its cognate guanine nucleotide exchange factor (GEF), Rabin8 (by using the Ser111Glu phosphorylation mimic). These findings provide the first evidence that PINK1 is able to regulate the phosphorylation of Rab GTPases and indicate that monitoring phosphorylation of Rab8A/8B/13 at Ser(111) may represent novel biomarkers of PINK1 activity in vivo. Our findings also suggest that disruption of Rab GTPase-mediated signalling may represent a major mechanism in the neurodegenerative cascade of Parkinson's disease. ",
keywords = "Amino Acid Substitution, Enzyme Activation, HEK293 Cells, HeLa Cells, Humans, Mutation, Missense, Oncogene Proteins, Parkinsonian Disorders, Phosphorylation, Protein Kinases, Protein-Serine-Threonine Kinases, rab GTP-Binding Proteins, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't",
author = "Yu-Chiang Lai and Chandana Kondapalli and Ronny Lehneck and Procter, {James B} and Dill, {Brian D} and Woodroof, {Helen I} and Robert Gourlay and Mark Peggie and Macartney, {Thomas J} and Olga Corti and Jean-Christophe Corvol and Campbell, {David G} and Aymelt Itzen and Matthias Trost and Muqit, {Miratul Mk}",
note = "{\textcopyright} 2015 The Authors. Published under the terms of the CC BY 4.0 license.",
year = "2015",
month = nov,
day = "12",
doi = "10.15252/embj.201591593",
language = "English",
volume = "34",
pages = "2840--61",
journal = "EMBO J",
issn = "0261-4189",
publisher = "NATURE PUBLISHING GROUP",
number = "22",

}

RIS

TY - JOUR

T1 - Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1

AU - Lai, Yu-Chiang

AU - Kondapalli, Chandana

AU - Lehneck, Ronny

AU - Procter, James B

AU - Dill, Brian D

AU - Woodroof, Helen I

AU - Gourlay, Robert

AU - Peggie, Mark

AU - Macartney, Thomas J

AU - Corti, Olga

AU - Corvol, Jean-Christophe

AU - Campbell, David G

AU - Itzen, Aymelt

AU - Trost, Matthias

AU - Muqit, Miratul Mk

N1 - © 2015 The Authors. Published under the terms of the CC BY 4.0 license.

PY - 2015/11/12

Y1 - 2015/11/12

N2 - Mutations in the PTEN-induced kinase 1 (PINK1) are causative of autosomal recessive Parkinson's disease (PD). We have previously reported that PINK1 is activated by mitochondrial depolarisation and phosphorylates serine 65 (Ser(65)) of the ubiquitin ligase Parkin and ubiquitin to stimulate Parkin E3 ligase activity. Here, we have employed quantitative phosphoproteomics to search for novel PINK1-dependent phosphorylation targets in HEK (human embryonic kidney) 293 cells stimulated by mitochondrial depolarisation. This led to the identification of 14,213 phosphosites from 4,499 gene products. Whilst most phosphosites were unaffected, we strikingly observed three members of a sub-family of Rab GTPases namely Rab8A, 8B and 13 that are all phosphorylated at the highly conserved residue of serine 111 (Ser(111)) in response to PINK1 activation. Using phospho-specific antibodies raised against Ser(111) of each of the Rabs, we demonstrate that Rab Ser(111) phosphorylation occurs specifically in response to PINK1 activation and is abolished in HeLa PINK1 knockout cells and mutant PINK1 PD patient-derived fibroblasts stimulated by mitochondrial depolarisation. We provide evidence that Rab8A GTPase Ser(111) phosphorylation is not directly regulated by PINK1 in vitro and demonstrate in cells the time course of Ser(111) phosphorylation of Rab8A, 8B and 13 is markedly delayed compared to phosphorylation of Parkin at Ser(65). We further show mechanistically that phosphorylation at Ser(111) significantly impairs Rab8A activation by its cognate guanine nucleotide exchange factor (GEF), Rabin8 (by using the Ser111Glu phosphorylation mimic). These findings provide the first evidence that PINK1 is able to regulate the phosphorylation of Rab GTPases and indicate that monitoring phosphorylation of Rab8A/8B/13 at Ser(111) may represent novel biomarkers of PINK1 activity in vivo. Our findings also suggest that disruption of Rab GTPase-mediated signalling may represent a major mechanism in the neurodegenerative cascade of Parkinson's disease.

AB - Mutations in the PTEN-induced kinase 1 (PINK1) are causative of autosomal recessive Parkinson's disease (PD). We have previously reported that PINK1 is activated by mitochondrial depolarisation and phosphorylates serine 65 (Ser(65)) of the ubiquitin ligase Parkin and ubiquitin to stimulate Parkin E3 ligase activity. Here, we have employed quantitative phosphoproteomics to search for novel PINK1-dependent phosphorylation targets in HEK (human embryonic kidney) 293 cells stimulated by mitochondrial depolarisation. This led to the identification of 14,213 phosphosites from 4,499 gene products. Whilst most phosphosites were unaffected, we strikingly observed three members of a sub-family of Rab GTPases namely Rab8A, 8B and 13 that are all phosphorylated at the highly conserved residue of serine 111 (Ser(111)) in response to PINK1 activation. Using phospho-specific antibodies raised against Ser(111) of each of the Rabs, we demonstrate that Rab Ser(111) phosphorylation occurs specifically in response to PINK1 activation and is abolished in HeLa PINK1 knockout cells and mutant PINK1 PD patient-derived fibroblasts stimulated by mitochondrial depolarisation. We provide evidence that Rab8A GTPase Ser(111) phosphorylation is not directly regulated by PINK1 in vitro and demonstrate in cells the time course of Ser(111) phosphorylation of Rab8A, 8B and 13 is markedly delayed compared to phosphorylation of Parkin at Ser(65). We further show mechanistically that phosphorylation at Ser(111) significantly impairs Rab8A activation by its cognate guanine nucleotide exchange factor (GEF), Rabin8 (by using the Ser111Glu phosphorylation mimic). These findings provide the first evidence that PINK1 is able to regulate the phosphorylation of Rab GTPases and indicate that monitoring phosphorylation of Rab8A/8B/13 at Ser(111) may represent novel biomarkers of PINK1 activity in vivo. Our findings also suggest that disruption of Rab GTPase-mediated signalling may represent a major mechanism in the neurodegenerative cascade of Parkinson's disease.

KW - Amino Acid Substitution

KW - Enzyme Activation

KW - HEK293 Cells

KW - HeLa Cells

KW - Humans

KW - Mutation, Missense

KW - Oncogene Proteins

KW - Parkinsonian Disorders

KW - Phosphorylation

KW - Protein Kinases

KW - Protein-Serine-Threonine Kinases

KW - rab GTP-Binding Proteins

KW - Journal Article

KW - Research Support, N.I.H., Extramural

KW - Research Support, Non-U.S. Gov't

U2 - 10.15252/embj.201591593

DO - 10.15252/embj.201591593

M3 - SCORING: Journal article

C2 - 26471730

VL - 34

SP - 2840

EP - 2861

JO - EMBO J

JF - EMBO J

SN - 0261-4189

IS - 22

ER -